204 related articles for article (PubMed ID: 24038155)
1. Estimating the loss in expectation of life due to cancer using flexible parametric survival models.
Andersson TM; Dickman PW; Eloranta S; Lambe M; Lambert PC
Stat Med; 2013 Dec; 32(30):5286-300. PubMed ID: 24038155
[TBL] [Abstract][Full Text] [Related]
2. Illustration of different modelling assumptions for estimation of loss in expectation of life due to cancer.
Andersson TM; Rutherford MJ; Lambert PC
BMC Med Res Methodol; 2019 Jul; 19(1):145. PubMed ID: 31288739
[TBL] [Abstract][Full Text] [Related]
3. Estimating the loss of lifetime function using flexible parametric relative survival models.
Jakobsen LH; Andersson TM; Biccler JL; El-Galaly TC; Bøgsted M
BMC Med Res Methodol; 2019 Jan; 19(1):23. PubMed ID: 30691400
[TBL] [Abstract][Full Text] [Related]
4. Estimating and modeling the cure fraction in population-based cancer survival analysis.
Lambert PC; Thompson JR; Weston CL; Dickman PW
Biostatistics; 2007 Jul; 8(3):576-94. PubMed ID: 17021277
[TBL] [Abstract][Full Text] [Related]
5. Estimating the proportion cured of cancer: some practical advice for users.
Yu XQ; De Angelis R; Andersson TM; Lambert PC; O'Connell DL; Dickman PW
Cancer Epidemiol; 2013 Dec; 37(6):836-42. PubMed ID: 24042025
[TBL] [Abstract][Full Text] [Related]
6. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates.
Chu PC; Wang JD; Hwang JS; Chang YY
Value Health; 2008 Dec; 11(7):1102-9. PubMed ID: 18489497
[TBL] [Abstract][Full Text] [Related]
7. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
[TBL] [Abstract][Full Text] [Related]
8. The loss in expectation of life after colon cancer: a population-based study.
Andersson TM; Dickman PW; Eloranta S; Sjövall A; Lambe M; Lambert PC
BMC Cancer; 2015 May; 15():412. PubMed ID: 25982368
[TBL] [Abstract][Full Text] [Related]
9. Estimating and modelling cure in population-based cancer studies within the framework of flexible parametric survival models.
Andersson TM; Dickman PW; Eloranta S; Lambert PC
BMC Med Res Methodol; 2011 Jun; 11():96. PubMed ID: 21696598
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Flexible Parametric Relative Survival Approaches for Enforcing Long-Term Constraints When Extrapolating All-Cause Survival.
Lee S; Lambert PC; Sweeting MJ; Latimer NR; Rutherford MJ
Value Health; 2024 Jan; 27(1):51-60. PubMed ID: 37858887
[TBL] [Abstract][Full Text] [Related]
11. Estimating expected survival probabilities for relative survival analysis--exploring the impact of including cancer patient mortality in the calculations.
Talbäck M; Dickman PW
Eur J Cancer; 2011 Nov; 47(17):2626-32. PubMed ID: 21924892
[TBL] [Abstract][Full Text] [Related]
12. Estimating the change in life expectancy after a diagnosis of cancer among the Australian population.
Baade PD; Youlden DR; Andersson TM; Youl PH; Kimlin MG; Aitken JF; Biggar RJ
BMJ Open; 2015 Apr; 5(4):e006740. PubMed ID: 25869684
[TBL] [Abstract][Full Text] [Related]
13. The impact of additional life-table variables on excess mortality estimates.
Grafféo N; Jooste V; Giorgi R
Stat Med; 2012 Dec; 31(30):4219-30. PubMed ID: 22806957
[TBL] [Abstract][Full Text] [Related]
14. Comparing Survival Extrapolation within All-Cause and Relative Survival Frameworks by Standard Parametric Models and Flexible Parametric Spline Models Using the Swedish Cancer Registry.
Chen EY; Leontyeva Y; Lin CN; Wang JD; Clements MS; Dickman PW
Med Decis Making; 2024 Apr; 44(3):269-282. PubMed ID: 38314657
[TBL] [Abstract][Full Text] [Related]
15. CANSURV: A Windows program for population-based cancer survival analysis.
Yu B; Tiwari RC; Cronin KA; McDonald C; Feuer EJ
Comput Methods Programs Biomed; 2005 Dec; 80(3):195-203. PubMed ID: 16257080
[TBL] [Abstract][Full Text] [Related]
16. Does minimum follow-up time post-diagnosis matter? An assessment of changing loss of life expectancy for people with cancer in Western Australia from 1982 to 2016.
Wright CM; Moorin RE
Cancer Epidemiol; 2020 Jun; 66():101705. PubMed ID: 32224327
[TBL] [Abstract][Full Text] [Related]
17. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964-2003 followed up to the end of 2006. Material and methods.
Engholm G; Gislum M; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):545-60. PubMed ID: 20491523
[TBL] [Abstract][Full Text] [Related]
18. Estimating the crude probability of death due to cancer and other causes using relative survival models.
Lambert PC; Dickman PW; Nelson CP; Royston P
Stat Med; 2010 Mar; 29(7-8):885-95. PubMed ID: 20213719
[TBL] [Abstract][Full Text] [Related]
19. Empirical estimation of life expectancy from large clinical trials: use of left-truncated, right-censored survival analysis methodology.
Nelson CL; Sun JL; Tsiatis AA; Mark DB
Stat Med; 2008 Nov; 27(26):5525-55. PubMed ID: 18613251
[TBL] [Abstract][Full Text] [Related]
20. Estimating mortality rates: the role of proportional life expectancy.
Anderson TW; Marion SA
J Insur Med; 2005; 37(1):35-41. PubMed ID: 15895696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
